Abstract
Background
Infections of the esophagus are rare and most commonly seen in children with immune suppression resulting from malignancy, chronic metabolic or infectious disease, or immunosuppressive drug therapy.
Methods
An 18-month-old girl on inhaled corticosteroid for bronchial asthma presented with coffee-ground emesis and melena. Upper endoscopy revealed yellow-white plaques scattered over the mucosa of the distal esophagus. Biopsy results showed chronic esophagitis with features of reflux disease. Gram staining of esophageal brushing showed pseudohyphae, and the culture was positive for candida species.
Results
The patient was treated with omeprazole 2 mg/kg per day and fluconazole 6 mg/kg per day for three weeks. Immunological workup was normal and she was negative for human immunodeficiency virus. Post treatment endoscopy showed normal appearance of esophageal mucosa and normal histology. At 12 months after treatment, the child remained asymptomatic and continued to thrive.
Conclusions
We believe that this child developed esophageal candidiasis secondary to long-term use of inhaled corticosteroid associated with immune suppression on a background of reflux esophagitis. Anti-acid and antifungal therapies are effective in the treatment.
Similar content being viewed by others
References
McDonald GB, Sharma P, Hackman RC, Meyers JD, Thomas ED. Esophageal infections in immunosuppressed patients after marrow transplantation. Gastroenterology 1985;88:1111–1117.
Misra S, Ament ME. Esophagitis. In: Feign RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. Philadelphia: WB Saunders, 1997: 562–566.
López-Dupla M, Mora Sanz P, Pintado García V, Valencia Ortega E, Uriol PL, Khamashta MA, et al. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. Am J Gastroenterol 1992;87:1771–1776.
Walsh TJ, Pizzo PA. Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Annu Rev Microbiol 1988;42:517–545.
Chocarro Martínez A, Galindo Tobal F, Ruiz-Irastorza G, González López A, Alvarez Navia F, Ochoa Sangrador C, et al. Risk factors for esophageal candidiasis. Eur J Clin Microbiol Infect Dis 2000;19:96–100.
Yacono JV. Type I herpes simplex esophagitis with candida1 esophagitis in an immunocompetent host. N Y State J Med 1985;85:656–658.
Mathieson R, Dutta SK. Candida esophagitis. Dig Dis Sci 1983;28:365–367.
Underwood JA, Williams JW, Keate RF. Clinical findings and risk factors for Candida esophagitis in outpatients. Dis Esophagus 2003;16:66–69.
Ostrosky-Zeichner L, Rex J, Bennett J. Deeply invasive candidiasis. Infect Dis Clin North Am 2002;16:821–835.
Billings CJ, Billings AM, Crissinger KD, Gremse DA. Candida esophagitis in infants with gastresophageal reflux disease and feeding intolerance. Am J Gastroenterol 2004;99Suppl:S315.
Uc A, North P, Burks W. Esophageal candidiasis in an infant with reflux esophagitis. J Pediatr Gastroenterol Nutr 2000;31:572–574.
Rahhal RM, Ramkumar DP, Pashankar DS. Simultaneous herpetic and candidal esophagitis in an immunocompetent teenager. J Pediatr Gastroenterol Nutr 2005;40:371–373.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hasosah, M.Y., Showail, M., Al-sahafi, A. et al. Esophageal candidiasis in an immunocompetent girl. World J Pediatr 5, 152–154 (2009). https://doi.org/10.1007/s12519-009-0031-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-009-0031-4